West Pharmaceutical Services (WST) P/B ratio

P/B ratio today
9.5×

West Pharmaceutical Services (WST) trades at 9.5× its book value per share at the end of fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/B ratio was 6.3×. That is 30.0% lower than the 9.0× of fiscal 2024. Figures as of 18 Nov 2026, 06:17 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/B ratio today
9.5×
P/B ratio, fiscal 2025
6.3×
Change on fiscal 2024
−30.0%
Highest on record
15.3×fiscal 2021
Lowest on record
2.1×fiscal 2011
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

West Pharmaceutical Services P/B ratio, in more detail

Today's figure is 50.5% above the fiscal 2025 year-end.

Across the 18 fiscal year-ends on record (2008–2025), the highest was 15.3× in fiscal 2021 and the lowest 2.1× in fiscal 2011. Today's P/B ratio is higher than at 89% of the 18 fiscal year-ends on record; their median is 5.5×.

History · 18 fiscal years

P/B ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

West Pharmaceutical Services P/B ratio, year by year

West Pharmaceutical Services (WST) P/B ratio by fiscal year
Fiscal yearP/B ratioChangeYear endedShare price at year-endBook value per share
Today9.5×—$414.12—
20256.3× 30.0% down$275.14$43.69
20249.0× 2.2% down$327.56$36.39
20239.2× 38.5% up$352.12$38.26
20226.6× 56.6% down$235.35$35.42
202115.3× 32.3% up$469.01$30.61
202011.6× 60.7% up$283.31$24.47
20197.2× 36.1% up$150.33$20.86
20185.3× 9.4% down$98.03$18.52
20175.8× 2.6% up$98.67$16.89
20165.7× 31.2% up$84.83$14.90
20154.3× 7.2% up$60.22$13.87
20144.1× 4.8% up$53.24$13.14
20133.9× 43.3% up$49.06$12.69
20122.7× 25.8% up$27.38$10.15
20112.1× 11.3% down$18.98$8.85
20102.4× 1.7% down$20.60$8.52
20092.5× 12.2% down$19.60$7.98
20082.8×—$18.89$6.75

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

How to read it

It compares the price with the accounting value of what the company owns net of what it owes, and matters most for banks, insurers and other balance-sheet businesses.

P/B ratio at health care companies of similar size

P/B ratio of West Pharmaceutical Services and comparable companies
CompanyP/B ratio
Labcorp Holdings LH3.5×
DexCom DXCM11.1×
Roivant Sciences ROIV6.2×
West Pharmaceutical Services WST9.1×
Quest Diagnostics DGX3.9×

Today's market value divided by shareholders' equity at the latest fiscal year-end. A company whose statements are in another currency than its shares is left out.

More on WST

West Pharmaceutical Services, figure by figure

West Pharmaceutical Services (WST) overview: price, valuation and scorecardAll health care companies by market value

West Pharmaceutical Services P/B ratio: questions and answers

What is West Pharmaceutical Services's P/B ratio?

West Pharmaceutical Services (WST) trades at 9.5× its book value per share at the end of fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/B ratio was 6.3×. That is 30.0% lower than the 9.0× of fiscal 2024.

Is West Pharmaceutical Services's P/B ratio high or low compared with its own history?

Today's P/B ratio is higher than at 89% of the 18 fiscal year-ends on record; their median is 5.5×.

What are the highest and lowest P/B ratio figures on record for West Pharmaceutical Services?

Across the 18 fiscal year-ends on record (2008–2025), the highest was 15.3× in fiscal 2021 and the lowest 2.1× in fiscal 2011.

How is West Pharmaceutical Services's P/B ratio calculated?

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “West Pharmaceutical Services (WST) P/B ratio”, data as of 18 November 2026. https://funkfolio.com/stock/WST/pb-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.